1. Surgical exploration
Complete evaluation of the abdominal cavity to determine the extent of disease and calculate the peritoneal carcinomatosis index (PCI).
Combined treatment of cytoreductive surgery and heated intra-abdominal chemotherapy for the treatment of peritoneal carcinomatosis with curative intent.
CONTACT SPECIALISTNeed to speak with a specialist?
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a procedure that combines cytoreductive surgery with the direct application of heated chemotherapy inside the abdominal cavity. It is used to treat tumors that have spread to the peritoneum (peritoneal carcinomatosis).
The goal is to remove all visible tumor implants through surgery and then apply heated chemotherapy to destroy residual microscopic cancer cells. Hyperthermia (heat) enhances the effect of chemotherapeutic drugs.
The HIPEC procedure is performed in the operating room under general anesthesia and consists of several phases:
Complete evaluation of the abdominal cavity to determine the extent of disease and calculate the peritoneal carcinomatosis index (PCI).
Removal of all visible tumor implants, including peritonectomies and resection of affected organs if necessary.
Perfusion of the abdominal cavity with chemotherapy heated to 41-43°C for 60-90 minutes, ensuring contact with all peritoneal surfaces.
Performing intestinal anastomoses and closing the abdominal cavity after draining the chemotherapy solution.
HIPEC is especially indicated for the following tumors with peritoneal involvement:
Mucinous appendiceal tumors with peritoneal spread. This is the indication with the best results, achieving long-term survival rates above 80%.
Primary tumor of the peritoneum where HIPEC has demonstrated significant survival benefit when complete cytoreduction is achieved.
HIPEC has shown benefit in advanced ovarian cancer, especially in the context of interval surgery after neoadjuvant chemotherapy.
In selected cases of colorectal carcinomatosis with low tumor burden and favorable biology.
HIPEC offers unique advantages in the treatment of peritoneal carcinomatosis:
Chemotherapy is administered directly where the disease is located, reaching concentrations up to 20 times higher than systemic chemotherapy.
When applied locally, systemic side effects are fewer than with conventional intravenous chemotherapy.
Hyperthermia increases the penetration and effectiveness of chemotherapeutic drugs in tumor tissue.
In selected indications, HIPEC offers the possibility of cure in patients who previously only had palliative options.
At Quenet-Torrent Institute we have one of the largest national and international experiences in cytoreductive surgery and HIPEC. Our team has performed more than 500 HIPEC procedures with oncological results published in high-impact scientific journals.
We work in a multidisciplinary environment that includes medical oncologists, radiologists, specialized anesthesiologists, and nursing staff with specific training in this complex procedure.
The HIPEC procedure is used in the treatment of various pathologies with peritoneal involvement.
Comprehensive treatment of peritoneal tumor spread from various origins.
More informationEspecially indicated in advanced ovarian cancer with carcinomatosis.
More informationIn selected cases of colorectal carcinomatosis.
More informationComplete the form and schedule your appointment to speak directly with the surgeon.